Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

10x Genomics, Inc. Director's Dealing 2023

Sep 18, 2023

31830_dirs_2023-09-18_d53ad8b8-18dc-404a-a47d-1a9c6bd21404.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2023-09-14

Reporting Person: Saxonov Serge (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-14 Class A Common Stock S 1920 $49.3509 Disposed 862173 Direct
2023-09-14 Class A Common Stock S 80 $49.82 Disposed 862093 Direct
2023-09-14 Class A Common Stock G 3167 Disposed 858926 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 27 Indirect
Class A Common Stock 870 Indirect
Class A Common Stock 183350 Indirect
Class A Common Stock 16320 Indirect

Footnotes

F1: The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022.

F2: This transaction was executed in multiple trades at prices ranging from $48.78 to $49.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $49.78 to $49.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

F5: The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.

F6: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

F7: The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.